Watts Ryan J. (CIK 1724310) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Sell DNLI (32,220 shares), Sell DNLI (35,198 shares), Buy DNLI (78,960 shares), Sell DNLI (50,000 shares), Buy DNLI (455,282 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Denali Therapeutics Inc. (DNLI) | President and CEO | Sell | 32,220 | $0 |
| 2026-01-08 | Denali Therapeutics Inc. (DNLI) | President and CEO | Sell | 35,198 | $580,767 |
| 2026-01-05 | Denali Therapeutics Inc. (DNLI) | President and CEO | Buy | 78,960 | $0 |
| 2025-09-05 | Denali Therapeutics Inc. (DNLI) | President and CEO | Sell | 50,000 | $0 |
| 2025-07-11 | Denali Therapeutics Inc. (DNLI) | President and CEO | Buy | 455,282 | $309,592 |
| 2025-07-11 | Denali Therapeutics Inc. (DNLI) | President and CEO | Buy | 40,000 | $211,200 |
| 2025-07-11 | Denali Therapeutics Inc. (DNLI) | President and CEO | Sell | 495,282 | $7.4M |
Source: SEC Form 4 filings · as of 2026-08-14